trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Kozłowska A and Jagodziński PP Effect of Trichostatin A on CD4 surface density in peripheral blood T cells. 2006 Folia Histochem. Cytobiol. pmid:17219719
Sestáková B and Vachtenheim J Distinct co-regulation of endogenous versus transfected MITF-dependent tyrosinase promoter. 2006 Folia Biol. (Praha) pmid:17116288
Zhu K et al. Expression characterization and the promoter activity analysis of zebrafish hdac4. 2012 Fish Physiol. Biochem. pmid:21773810
Suo L et al. Changes in acetylation on lysine 12 of histone H4 (acH4K12) of murine oocytes during maternal aging may affect fertilization and subsequent embryo development. 2010 Fertil. Steril. pmid:19285668
Guo SW et al. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. 2013 Fertil. Steril. pmid:22999795
Lee E et al. Involvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosis. 1996 FEBS Lett. pmid:8898091
Miyashita T et al. Activation of the mouse cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin A. 1994 FEBS Lett. pmid:7523197
Khan DH and Davie JR HDAC inhibitors prevent the induction of the immediate-early gene FOSL1, but do not alter the nucleosome response. 2013 FEBS Lett. pmid:23542037
Chou CW and Chen CC HDAC inhibition upregulates the expression of angiostatic ADAMTS1. 2008 FEBS Lett. pmid:19007777
Bernes S et al. Epigenetic and classical activation of Entamoeba histolytica heat shock protein 100 (EHsp100) expression. 2005 FEBS Lett. pmid:16263115
An JH et al. The expression of p21 is upregulated by forkhead box A1/2 in p53-null H1299 cells. 2014 FEBS Lett. pmid:25281925
Della Ragione F et al. Genes modulated by histone acetylation as new effectors of butyrate activity. 2001 FEBS Lett. pmid:11423116
Duhamel M et al. Differential epigenetic regulation of Aiolos expression in human tumoral cell lines and primary cells. 2008 FEBS Lett. pmid:18206652
Politis PK et al. BM88/Cend1 is involved in histone deacetylase inhibition-mediated growth arrest and differentiation of neuroblastoma cells. 2008 FEBS Lett. pmid:18258204
Kim YB et al. phd1+, a histone deacetylase gene of Schizosaccharomyces pombe, is required for the meiotic cell cycle and resistance to trichostatin A. 1998 FEBS Lett. pmid:9781677
Wan Y et al. Transcriptome profiling reveals a novel role for trichostatin A in antagonizing histone chaperone Chz1 mediated telomere anti-silencing. 2011 FEBS Lett. pmid:21763693
Wang QH et al. Opposite effects of Trichostatin A on activation of mast cells by different stimulants. 2010 FEBS Lett. pmid:20371366
Hitomi T et al. p15(INK4b) in HDAC inhibitor-induced growth arrest. 2003 FEBS Lett. pmid:14623092
Yokota T et al. Trichostatin A activates p18INK4c gene: differential activation and cooperation with p19INK4d gene. 2004 FEBS Lett. pmid:15358560
Pourebrahim R et al. ZIC1 gene expression is controlled by DNA and histone methylation in mesenchymal proliferations. 2007 FEBS Lett. pmid:17936758
Grandjean V et al. Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain. 2001 FEBS Lett. pmid:11163765
Mishra SK et al. Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells. 2001 FEBS Lett. pmid:11682064
Jackson MF et al. Genetic manipulation of myoblasts and a novel primary myosatellite cell culture system: comparing and optimizing approaches. 2013 FEBS J. pmid:23173931
Pan L et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. 2010 FEBS J. pmid:20089040
Seo J et al. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity. 2013 FEBS J. pmid:24200051
Young DA et al. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. 2005 FEBS J. pmid:15819885
Icardi L et al. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. 2012 FASEB J. pmid:21957129
Yan C et al. A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. 2004 FASEB J. pmid:14715692
Krishnan M et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. 2006 FASEB J. pmid:16246867
Chambliss AB et al. Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution. 2013 FASEB J. pmid:23538711
Aung HT et al. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. 2006 FASEB J. pmid:16816106
Gurvich N et al. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. 2005 FASEB J. pmid:15901671
Chandrasekaran S et al. Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes. 2009 FASEB J. pmid:19638401
Corelli F et al. [Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin A]. 1987 Farmaco Sci pmid:3329612
Ganatra DA et al. Association of histone acetylation at the ACTA2 promoter region with epithelial mesenchymal transition of lens epithelial cells. 2015 Eye (Lond) pmid:25853442
Williams RJ Trichostatin A, an inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis. 2001 Expert Opin Investig Drugs pmid:11785457
Azzi A et al. Schistosoma mansoni: developmental arrest of miracidia treated with histone deacetylase inhibitors. 2009 Exp. Parasitol. pmid:19094990
Zhang S et al. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. 2008 Exp. Oncol. pmid:19112422
Yoo YE and Ko CP Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. 2011 Exp. Neurol. pmid:21712032
Yildirim F et al. Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. 2008 Exp. Neurol. pmid:18234195
Jayaraman A et al. Amelioration of progressive autoimmune encephalomyelitis by epigenetic regulation involves selective repression of mature neutrophils during the preclinical phase. 2018 Exp. Neurol. pmid:29453977
Woo HJ et al. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. 2007 Exp. Mol. Pathol. pmid:16574101
Yamamura N and Kishimoto T Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma. 2012 Exp. Mol. Pathol. pmid:22472323
Yang J et al. PTEN methylation involved in benzene-induced hematotoxicity. 2014 Exp. Mol. Pathol. pmid:24680972
Oliva J et al. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. 2008 Exp. Mol. Pathol. pmid:18280469
Yi T et al. Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis. 2007 Exp. Mol. Med. pmid:17464183
Jang ER et al. ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response. 2010 Exp. Mol. Med. pmid:20164679
Kang JH et al. Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1. 2007 Exp. Mol. Med. pmid:17603295
Kim TY et al. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells. 2008 Exp. Mol. Med. pmid:19116449
Kim HR et al. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway? 2006 Exp. Mol. Med. pmid:17202837
Ota C et al. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo. 2015 Exp. Lung Res. pmid:26151196
Schuhmann NK et al. Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors. 2010 Exp. Hematol. pmid:20447441
Hsiao CH et al. Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. 2006 Exp. Hematol. pmid:16543060
Gao SM et al. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms. 2013 Exp. Hematol. pmid:23111066
Araki H et al. Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues. 2009 Exp. Hematol. pmid:19501128
Tshuikina M et al. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma. 2008 Exp. Hematol. pmid:18922617
Pace BS et al. p38 MAP kinase activation mediates gamma-globin gene induction in erythroid progenitors. 2003 Exp. Hematol. pmid:14585374
Araki H et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. 2006 Exp. Hematol. pmid:16459182
Scott SA et al. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. 2007 Exp. Hematol. pmid:17258075
Kypreou KP et al. Age-dependent response of lymphocytes in the induction of the linker histone variant, H1 degrees and histone H4 acetylation after treatment with the histone deacetylase inhibitor, trichostatin A. 2004 Exp. Gerontol. pmid:15050280
Sourlingas TG et al. The effect of the histone deacetylase inhibitor, trichostatin A, on total histone synthesis, H1(0) synthesis and histone H4 acetylation in peripheral blood lymphocytes increases as a function of increasing age: a model study. 2002 Jan-Mar Exp. Gerontol. pmid:11772521
Robertson DM et al. Insulin-like Growth Factor Binding Protein-3 expression in the human corneal epithelium. 2007 Exp. Eye Res. pmid:17709104
Horswill MA et al. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. 2008 Exp. Eye Res. pmid:18291368
Alsarraf O et al. Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration. 2014 Exp. Eye Res. pmid:25064603
Hrgovic I et al. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism. 2017 Exp. Dermatol. pmid:27487811
Khan Z et al. HDAC inhibition amplifies gap junction communication in neural progenitors: potential for cell-mediated enzyme prodrug therapy. 2007 Exp. Cell Res. pmid:17555745
Han Y et al. Murine hematopoietic stem cell dormancy controlled by induction of a novel short form of PSF1 by histone deacetylase inhibitors. 2015 Exp. Cell Res. pmid:25933513
Di Zanni E et al. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells. 2015 Exp. Cell Res. pmid:25882494
Aoyama K et al. Nuclear c-Abl-mediated tyrosine phosphorylation induces chromatin structural changes through histone modifications that include H4K16 hypoacetylation. 2011 Exp. Cell Res. pmid:22001646
Sundqvist A et al. Functional knockout of the corepressor CtBP by the second exon of adenovirus E1a relieves repression of transcription. 2001 Exp. Cell Res. pmid:11478854
Eriksson I et al. The histone deacetylase inhibitor trichostatin A reduces lysosomal pH and enhances cisplatin-induced apoptosis. 2013 Exp. Cell Res. pmid:23063877
McBurney MW et al. Evidence for repeat-induced gene silencing in cultured Mammalian cells: inactivation of tandem repeats of transfected genes. 2002 Exp. Cell Res. pmid:11855851
Hou M et al. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. 2002 Exp. Cell Res. pmid:11855854
Duncan HF et al. Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells. 2013 Exp. Cell Res. pmid:23562654
Tiernan AR et al. Trichostatin A affects the secretion pathways of beta and intestinal endocrine cells. 2015 Exp. Cell Res. pmid:25305500
Vulcano F et al. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers. 2006 Exp. Cell Res. pmid:16739251
Yoshida M and Beppu T Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. 1988 Exp. Cell Res. pmid:3134246
Hoshikawa Y et al. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. 1994 Exp. Cell Res. pmid:8082721
Rombouts K et al. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. 2002 Exp. Cell Res. pmid:12169274
Astrand C et al. Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter. 2009 Exp. Cell Res. pmid:19463811
Ullerås E et al. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer. 2001 Exp. Cell Res. pmid:11640883
Gray SG et al. IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells. 1999 Exp. Cell Res. pmid:10585285
Giustiniani J et al. Basal endothelial nitric oxide synthase (eNOS) phosphorylation on Ser(1177) occurs in a stable microtubule- and tubulin acetylation-dependent manner. 2009 Exp. Cell Res. pmid:19632222
Rahmani M et al. The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated process. 2002 Exp. Cell Res. pmid:12061815
Kim MS et al. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). 2005 Exp. Cell Res. pmid:15878336
Mielnicki LM et al. Epigenetic regulation of gelsolin expression in human breast cancer cells. 1999 Exp. Cell Res. pmid:10328963
Travers H et al. Human CD34+ hematopoietic progenitor cells hyperacetylate core histones in response to sodium butyrate, but not trichostatin A. 2002 Exp. Cell Res. pmid:12413881
Nakajima H et al. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. 1998 Exp. Cell Res. pmid:9633520
Kato A et al. Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions. 2008 Exp. Cell Res. pmid:18588874
List HJ et al. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter. 1999 Exp. Cell Res. pmid:10527637
Karvonen U et al. Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. 2006 Exp. Cell Res. pmid:16860317
Law AY et al. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. 2008 Exp. Cell Res. pmid:18652825
Munro J et al. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. 2004 Exp. Cell Res. pmid:15093749
Matteucci E et al. Epigenetic control of endothelin-1 axis affects invasiveness of breast carcinoma cells with bone tropism. 2013 Exp. Cell Res. pmid:23660387
Law AY and Wong CK Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. 2010 Exp. Cell Res. pmid:19786016
Min XJ et al. Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells. 2011 Exp. Biol. Med. (Maywood) pmid:21454376
Zein S et al. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line. 2010 Exp. Biol. Med. (Maywood) pmid:20975082
Yang H et al. Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells. 2010 Exp. Biol. Med. (Maywood) pmid:20404016
Vadnal J et al. Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease. 2012 Exp Brain Res pmid:22811216
Dombrowsky H and Uhlig S Steroids and histone deacetylase in ventilation-induced gene transcription. 2007 Eur. Respir. J. pmid:17626110